Skip to content

New DNA computer stores long-term cellular memory.

The exciting field of biocomputing, involving processing and storing information in living cells, is currently being developed with a view to next-generation therapeutics and for capturing events within the body. A computation is the execution of an algorithm, a list of instructions that takes an input, processes it, and produces a result. In DNA computing, input is represented using the four-character genetic alphabet, adenine, guanine, cytosine, and thymine, rather than the binary alphabet used by traditional computers. However, DNA computational technology has only been able to capture and record a limited number of molecular events in the body, meaning they cannot be used over long periods of time. Now, a study from researchers at MIT programs human and bacterial cells to keep a record of complex molecular events over a long length of time. The team states their DNA-based Ordered Memory and Iteration Network Operator (DOMINO) could one day track the changes which occur from generation to generation as cells differentiate, or create sensors capable of detecting, and possibly even treating, diseased cells. The opensource study is published in the journal Molecular Cell.

Previous studies show existing biocomputers have limited recording capacity and are challenging to scale. Recent studies from the group developed a technique able to place new DNA sequences into predetermined locations in the genome in bacterial cells. In 2016, they developed a memory storage system based on CRISPR, a genome-editing system consisting of a DNA-cutting enzyme called Cas9 and a short RNA strand responsible for guiding the enzyme to a specific area of the genome. This CRISPR-based process allowed the researchers to insert mutations at specific DNA locations, however, the mutational outcomes were not always predictable and limited the amount of information stored. The current study uses a variant of CRISPR with the ability to precisely edit DNA bases, to store complex memories in the DNA of living cells, including human cells.

The current study attaches a version of the CRISPR-Cas9 enzyme to a recently developed base editor enzyme, which converts the nucleotide cytosine to thymine without breaking the double-stranded DNA. Results show guide RNA strands, which direct the base editor were to make this switch, are produced only when certain inputs are present in the cell. Data findings show when one of the target inputs is present, the guide RNA leads the base editor either to a stretch of DNA the researchers added to the cell’s nucleus, or to genes found in the cell’s own genome, depending on the application; measuring the resulting cytosine to thymine mutations determines what the cell has been exposed to.

The lab states they used DOMINO to create circuits with the capacity to perform logic calculations, detect the presence of multiple inputs, and record a cascade of events occurring in a certain order. They go on to add their DNA computer can be used to record the intensity, duration, sequence, and timing of many events in the life of a cell, such as exposures to certain chemicals; this memory-storage capacity can act as the foundation of complex circuits in which one event, or series of events, triggers another event, such as the production of a fluorescent protein.

The team surmises they have developed a DNA computer extending the utility of molecular recording beyond DNA write-only applications and enables long-term recording and monitoring of in vivo molecular events. For the future, the researchers state these new ‘living sensors’ may one day be able to sense pathogens and toxins in the body.

Source: Massachusetts Institute of Technology

 

Get Healthinnovations delivered to your inbox:

 

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.